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iscussion
r Lamberti (San Diego, Calif). Dr Hawkins and his colleagues
ave reported their results for aortic or systemic semilunar valve
epair in infants and children since 1991. If we look back over the
ast 20 years, we can identify 2 other operations that were pro-
osed for aortic valve disease in infants and children that have not
ithstood the test of time. After 1985, aortic homograft valves
ere generally available for use in infants and children. In addi-
ion, the general availability of homograft valves led to enthusiasm
or the Ross operation as a potentially curative operation for
hildren. At the meeting of this association in June 1992 in Kauai,
awaii, Dr David Clarke reported on his extensive experience with
ortic valve homografts in young patients. Dr Clarke reported that
ryopreserved aortic valve homografts degenerated rather quickly
n infants and children less than 3 years of age. For many of us the
oss operation seemed to offer an excellent option for the treat-
ent of important aortic valve disease in infants, children, and c
316 The Journal of Thoracic and Cardiovascular Surgery ● Maoung adults. Mid- to long-term follow-up of patients undergoing
he Ross operation has not supported the concept that replacing the
ortic valve with the native pulmonary valve with the technique of
oot replacement is a durable substitute for the aortic valve. Today
he surgeon confronted with a severe case of systemic semilunar
alve insufficiency has no ideal option for treatment, particularly
n infants and small children. Although the neonatal Ross opera-
ion can save the life of an infant, the patient will face multiple
eoperations on the right ventricular outflow tract and the possi-
ility that late replacement of the aortic graft will be required.
Dr Hawkins’ data indicate that repair and re-repair can be
ccomplished with an extremely low risk of mortality. The uni-
ariate analysis of risk factors leading to reintervention does not
elp us much in determining when repair is more appropriate than
eplacement. The results for repair of nontrileaflet anatomic aortic
alves are encouraging and suggest that the group from Utah have
knack for this type of surgery. Other reports in the literature do
ot indicate that repair for nontrileaflet aortic valves is guaranteed
o be successful. I have several questions.
In the “Discussion” of the article, the authors indicate that
mportant post-repair insufficiency was not a predictor of late
ntervention because no patient left the operating room with sig-
ificant residual aortic insufficiency. We know how many patients
nderwent a repair. I think it would help if we knew how many
atients entered the operating room with the surgeon intending to
epair but left the operating room with a valve replacement. Com-
arison of these 2 groups of patients might shed some additional
ight on the decision-making process of repair versus replacement.
Dr Hawkins. I think that is an excellent question. Unfortu-
ately I do not have the exact answer for you. I think that the
nswer probably has changed between the beginning of this study
nd today. I think 10 or 15 years ago that child would have been
uch more likely, the cases that I intended to repair; first of all I
id not go into the operating room 15 years ago intending to repair
hat many valves. Now I do, so that has changed. I think 15 years
go I would have been more likely to replace the valve, although
he Ross procedure, at least in Utah, did not really come into being
ntil about 1994. The options were few, so we probably would
ave replaced it, but it would have been a mechanical valve at that
oint in time. I would say today this is a long answer to a short
uestion; probably I would say 60% to 70% of the patients who
nter the operating room with the intention to repair, maybe even
igher, leave with a repair. Very infrequently do I replace the
alve, and I think that the reason for this all to evolve, for me
nyway, is the old adage that necessity is the mother of invention.
ust as you mentioned, an infant with truncus arteriosus and bad
nsufficiency, I mean what choice is there other than a homograft
o replacement and condemn that child to multiple operations.
hat’s a long answer, but I would say probably the majority of
hem leave with the repair at this point in time, in 2006.
Dr Lamberti. How do you decide whether to do subcommis-
ural annuloplasty or a circumferential annuloplasty? Is it based
otally on the size of the patient?
Dr Hawkins. No. It is based on how close to the normal size
f the annulus that the annulus is. So if it is 2 or 3 mm bigger than
hat the annulus should be, then I use the subcommissural, and
learly in the small children that is usually what is used. In the
ircumferential I use an annulus that appears to be normal, al-
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Hawkins et al Surgery for Congenital Heart Diseasehough I’ve used it in a few small children, and this really is not in
he article I don’t think, but I’ve used an absorbable suture, taken
his from an article that I heard from Switzerland in which they
ere using a polydioxanone ring for the mitral valve in children
ith rheumatic fever in Northern Africa. I have used polydiox-
none sutures, circumferential polydioxanone sutures, and I have
o idea how that turns out.
Dr Lamberti. That is in the article. You did not use any
omograft valves in the patients who came for replacement. Do
ou use aortic homograft valves in the aortic position at your
nstitution?
Dr Hawkins. No. I have in the past but not for the last 5 years.
Dr Lamberti. Do you create stenosis with your subcommis-
ural annuloplasty? It looked to me like the example that you
resented had a turbulence during systole.
Dr Hawkins. That particular patient did not have a subcom-
issural annuloplasty. This was a patient with rheumatic fever
ho had a trileaflet valve and a cusp extension. I think that does
reate some mild stenosis, and I think Chris Calderone and his
roup from Toronto presented an article at the Society of Thoracic
urgeons this year demonstrating that the little bit of stenosis you
et with a 3-leaflet augmentation is not really of any consequence
ong term.
Dr Lamberti. Finally, how should we interpret the data?
our results in 18 patients aged less than 4 years are excellent,
articularly in comparison with other alternatives. Should we g
The Journal of Thoraciclways try to repair the functional aortic valve when a Ross
rocedure is a realistic option, or is it better to postpone the
oss operation if the repair seems reasonable?
Dr Hawkins. That’s a really hard question. I guess it has
hanged for me, John, over the last few years. I now enter the
perating room with the intent to repair, and the Ross is a second-
ry backup even in the small children. It is a judgment call. I tell
he parents this: My decision to repair is based on whether I
elieve that when I finish I’m going to have a result that is going
o last longer than the Ross. If I do, then I repair it. If I don’t, then
do a Ross.
Dr Clarke (Denver, Colo). John, I enjoyed your presentation
ery much. You had 5 patients who had quadricuspid truncal
alves in your series, but I really did not see any specific reference
o the technique that you used to handle these. As you know, the
roup in Chicago has championed the technique of leaflet resection
ith or without coronary reimplantation. I’m curious as to how
ou handle these valves.
Dr Hawkins. I have not used the Chicago technique. I’ve been
ervous to chop a valve up and try to put it back together. My
pproach on those valves that I did not include, I put those under
usp repair. What I have generally done is to take a quadricuspid
alve and make it into a tricuspid valve. I try to pick the leaflet that I
hink is prolapsing or is the cause of the insufficiency, and I think that
s best determined on the short-axis view of your TEE, you can
enerally tell where that is, and try to bolster it and make it work.
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